Investors
Stock
Information
EURONEXT PARIS / B COMPARTMENT
FR0004065605 / MEDCL
25,143,553
KEPLER CHEUVREUX
BRYAN GARNIER & CO
KEPLER CHEUVREUX
ODDO-BHF
Investors
Events &
Presentations
PREVIOUS EVENTS
April 23, 2020
Video Conference • Adapt and overcome to the Covid-19 crisis
Replay
See all
Session en français
Rendez-vous le mardi 14 juin à 18h30 (CEST) pour une vidéoconférence dédiée aux résultas annuel 2021-2022
English session
On Tuesday 14, June at 7.30 pm (CEST) participate in our videoconference dedicated to our Financial year 2021-2022 results
INVESTORS
Regulated informations
July 2022 Half-year Liquidity contract statement
Jan. 2022 Half-year liquidity contract statement
See allDec. 2021 Half-Year report (French)
July 2021 Half-year liquidity contract statement
Jan. 2021 Half-year liquidity contract statement
Dec. 2020 Half year report (French)
July 2020 Half-year liquidity contract statement
Jan. 2020 Half-year liquidity contract statement
Jan. 2020 Half-Year liquidity contract report (French)
Dec. 2019 Half year report (French)
2018/2019 Annual financial report (French)
July 2019 Half year liquidity contract (French)
Shares & Voting rights
See allInvestors
General
Meeting
September 2022
See all
See all
See all
See all
See all
Investors
Contacts
MedinCell
Head of Communication / IR
David Heuzé
david.heuze@medincell.com
+33 (0)6 83 25 21 86
MedinCell
Senior Communications Officer
Nicolas Gourgues
nicolas.gourgues@medincell.com
Investor Relations
NewCap
Louis-Victor Delouvrier & Mathilde Bohin
medincell@newcap.eu
+33 (0)1 44 71 94 94
Media
NewCap
Nicolas Merigeau
medincell@newcap.eu
+33 (0)1 44 71 94 94